Your browser doesn't support javascript.
loading
T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma.
Woroniecka, Karolina; Chongsathidkiet, Pakawat; Rhodin, Kristen; Kemeny, Hanna; Dechant, Cosette; Farber, S Harrison; Elsamadicy, Aladine A; Cui, Xiuyu; Koyama, Shohei; Jackson, Christina; Hansen, Landon J; Johanns, Tanner M; Sanchez-Perez, Luis; Chandramohan, Vidyalakshmi; Yu, Yen-Rei Andrea; Bigner, Darell D; Giles, Amber; Healy, Patrick; Dranoff, Glenn; Weinhold, Kent J; Dunn, Gavin P; Fecci, Peter E.
Afiliação
  • Woroniecka K; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Chongsathidkiet P; Department of Pathology, Duke University Medical Center, Durham, North Carolina.
  • Rhodin K; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Kemeny H; Department of Pathology, Duke University Medical Center, Durham, North Carolina.
  • Dechant C; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Farber SH; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Elsamadicy AA; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Cui X; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Koyama S; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Jackson C; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Hansen LJ; Department of Medical Oncology and Cancer Vaccine Center, Dana Farber Cancer Institute, Boston, Massachusetts.
  • Johanns TM; Department of Neurosurgery, Johns Hopkins University, Baltimore, Maryland.
  • Sanchez-Perez L; Department of Pharmacology and Molecular Cancer Biology, Duke University, Durham, North Carolina.
  • Chandramohan V; Division of Medical Oncology, Department of Medicine, Washington University, St. Louis, Missouri.
  • Yu YA; Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Bigner DD; Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Giles A; Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Healy P; Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.
  • Dranoff G; Neuro-oncology Division, National Institutes of Health, Bethesda, Maryland.
  • Weinhold KJ; Department of Biostatistics, Duke University, Durham, North Carolina.
  • Dunn GP; Department of Medical Oncology and Cancer Vaccine Center, Dana Farber Cancer Institute, Boston, Massachusetts.
  • Fecci PE; Department of Surgery, Duke University Medical Center, Durham, North Carolina.
Clin Cancer Res ; 24(17): 4175-4186, 2018 09 01.
Article em En | MEDLINE | ID: mdl-29437767

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Linfócitos do Interstício Tumoral / Receptores de Antígenos de Linfócitos T alfa-beta / Glioblastoma Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Linfócitos do Interstício Tumoral / Receptores de Antígenos de Linfócitos T alfa-beta / Glioblastoma Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article